Education
About Us
Working with TipRanks
Follow Us
Electrocore (ECOR)
:ECOR
ECOR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.16 - $19.49
Previous CloseN/A
Volume24.66K
Average Volume (3M)102.66K
Market Cap
$40.27M
Enterprise Value$40.75M
Total Cash (Recent Filing)$7.39M
Total Debt (Recent Filing)$4.23M
Price to Earnings (P/E)―
Beta1.55
Next Earnings
Nov 13, 2025EPS Estimate
-0.38Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.44
Shares Outstanding7,583,445
10 Day Avg. Volume71,813
30 Day Avg. Volume102,657
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.01
Enterprise Value/Revenue1.47
Enterprise Value/Gross Profit1.72
Enterprise Value/Ebitda-3.32
Forecast
1Y Price Target
$20.13Price Target Upside279.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Bulls Say, Bears Say
Bulls Say
Acquisition ImpactThe acquisition of NeuroMetrix is expected to be accretive to both the top and bottom line for ECOR, increasing the company’s total addressable market and diversifying its portfolio of non-invasive wellness products.
Capital PositionElectroCore has sufficient capital to fund operations for the foreseeable future, following a debt term facility raising net proceeds of $7.2M.
Revenue GrowthECOR's above-consensus 2Q25 revenue growth reflected the commercial traction of Truvaga and VA channel expansion.
Bears Say
Profitability DelaysThe stock is down mainly due to the delayed company-wide profitability.
Revenue GuidanceLower-than-expected 2025 revenue guidance introduced, with the company expecting $30M, representing 19.1% y/y growth, below prior consensus and estimates.
Sales DeclineTruvaga sales experienced a modest sequential decline, despite a strong YoY growth of 74%.
Electrocore News
ECOR FAQ
What was Electrocore’s price range in the past 12 months?
Electrocore lowest stock price was $4.16 and its highest was $19.49 in the past 12 months.
What is Electrocore’s market cap?
Electrocore’s market cap is $40.27M.
When is Electrocore’s upcoming earnings report date?
Electrocore’s upcoming earnings report date is Nov 13, 2025 which is in 72 days.
How were Electrocore’s earnings last quarter?
Electrocore released its earnings results on Aug 06, 2025. The company reported -$0.44 earnings per share for the quarter, missing the consensus estimate of -$0.325 by -$0.115.
Is Electrocore overvalued?
According to Wall Street analysts Electrocore’s price is currently Undervalued.
Does Electrocore pay dividends?
Electrocore does not currently pay dividends.
What is Electrocore’s EPS estimate?
Electrocore’s EPS estimate is -0.38.
How many shares outstanding does Electrocore have?
Electrocore has 7,583,445 shares outstanding.
What happened to Electrocore’s price movement after its last earnings report?
Electrocore reported an EPS of -$0.44 in its last earnings report, missing expectations of -$0.325. Following the earnings report the stock price went down -29.149%.
Which hedge fund is a major shareholder of Electrocore?
Currently, no hedge funds are holding shares in ECOR
Electrocore Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$20.13 (279.10% Upside)
$20.13 (279.10% Upside)
Blogger Sentiment
Bullish
ECOR Sentiment 70%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $71.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 2.1%
Last 30 Days ▼ 6.0%
Last 30 Days ▼ 6.0%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-11.51%
12-Months-Change
Fundamentals
Return on Equity
-210.58%
Trailing 12-Months
Asset Growth
-34.87%
Trailing 12-Months
Company Description
Electrocore
Electrocore, Inc. (ECOR) is a medical technology company focused on the development and commercialization of non-invasive electroceutical therapies for the treatment of neurological and other disorders. The company specializes in its proprietary transcutaneous vagus nerve stimulation (tVNS) technology, which aims to provide patients with effective treatment options for conditions such as cluster headaches, migraines, and other chronic pain disorders. Electrocore operates primarily in the healthcare sector, leveraging its innovative technology to enhance patient care and outcomes.
ECOR Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with strong revenue growth and successful acquisitions on the positive side, but also highlighted challenges such as declining prescription revenues and increased operating expenses leading to a higher net loss. The strategy to invest in growth postpones profitability but aims for long-term value creation.View all ECOR earnings summariesECOR Stock 12 Month Forecast
Average Price Target
$20.13
▲(279.10% Upside)
Technical Analysis
Ownership Overview
20.19% Insiders
3.99% Mutual Funds
6.99% Other Institutional Investors
65.98% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---